NCT05751694

Brief Summary

Objective: check the effectiveness of visceral manual therapy on bruxist patients Design: Experimental, analytical, longitudinal, prospective, randomized, single-blind study with a blinded evaluator. Subjects: 68 subjects over 18 years old, with bruxism (diagnoses by a dentist). Methods: Subjects will be randomized into 2 groups: an experimental group (EG) to which a visceral manual technique will be applied and a control group (CG) to which a placebo manual technique will be administered. Both groups will receive 2 interventions one week apart. The measurements will be made before and after the interventions, and a last measurement will be made one month after the last intervention. Therefore, the patient will visit the center 3 times.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 2, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

February 26, 2025

Status Verified

May 1, 2024

Enrollment Period

2 years

First QC Date

February 8, 2023

Last Update Submit

February 23, 2025

Conditions

Keywords

BruxismMusculoskeletal ManipulationsPhysical Therapy ModalitiesAutonomic Nervous System

Outcome Measures

Primary Outcomes (15)

  • Pressure pain threshold (PPT) Baseline-1

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Baseline pre-intervention

  • PPT Change-1

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Change from "PTT Baseline-1" immediately post-intervention

  • PPT Baseline-2

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Baseline pre-intervention at 7 days

  • PPT Change-2

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Change from "PTT Baseline-2" immediately post-intervention

  • PPT Change-3

    The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Change from "PTT Baseline-2" and "PTT Change-2" at 1 month

  • Heart Rate Variability (HRV) Baseline-1

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Baseline pre-intervention

  • HRV Change-1

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Change from "HRV baseline-1" inmediately post-intervention

  • HRV Baseline-2

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Baseline pre-intervention at 7 days

  • HRV Change-2

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Change from "HRV baseline-2" inmediately post-intervention

  • HRV Change-3

    Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

    Change from "HRV baseline-2" and "HRV change-2" at 1 month

  • Myotonometry baseline-1

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Baseline pre-intervention

  • Myotonometry change-1

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Change from "myotonometry baseline-1" inmediately post-intervention

  • Myotonometry baseline-2

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Baseline pre-intervention at 7 days

  • Myotonometry change-2

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Change from "myotonometry baseline-2" inmediately post-intervention

  • Myotonometry change-3

    The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

    Change from "myotonometry baseline-2" and "myotonometry change-2" at 1 month

Secondary Outcomes (14)

  • Cervical Range of Motion (CROM) Baseline-1

    Baseline pre-intervention

  • Cervical Range of Motion (CROM) Change-1

    Change from "CROM Baseline-1" immediately post-intervention

  • Cervical Range of Motion (CROM) Baseline-2

    Baseline pre-intervention at 7 days

  • Cervical Range of Motion (CROM) Change-2

    Change from "CROM Baseline-2" immediately post-intervention

  • Cervical Range of Motion (CROM) Change-3

    Change from "CROM Baseline-2" and "CROM Change-2" at 1 month

  • +9 more secondary outcomes

Study Arms (2)

Visceral manual treatment

EXPERIMENTAL

The objective of this technique is to reduce the tension of the tissues of the epigastric area.

Procedure: Visceral manual treatment

Respiratory listening

ACTIVE COMPARATOR

It is a maneuver to evaluate the mobility of the ribs during respiration.

Procedure: Respiratory listening

Interventions

The patient will be placed in a reclining sitting position and triple flexion of the lower limbs to keep the abdominal region relaxed. The therapist will be placed to the right of the patient at the height of the abdomen, with the hands placed in the epigastric area. He will make a skin fold that reduces tension in the area, so that the contact is focused on the visceral tissue of the area. The patient will be asked to take deep breaths, and during the exhalation, the therapist will perform a zigzag movement with vibration of the hands while pulling the tissue caudally. This procedure will be performed for 5 minutes.

Visceral manual treatment

The patient and the therapist will be placed in the same position as in the experimental group. The therapist will place his hands in contact with the lower rib cage, and the patient will be asked to take a deep breath. The therapist will not exert any pressure, nor place restrictions on the tissues or movements of the ribcage.

Respiratory listening

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects with bruxism diagnosed and referred by a dentist
  • Age: older than 18 years-old.

You may not qualify if:

  • Recent craniofacial, mandibular or cervical trauma or fracture.
  • Temporomandibular joint surgery.
  • Acute pain due to other components of the masticatory system (caries, inflammation of the dental root).
  • Abdominal surgery.
  • Gastric ulcers.
  • Gastritis.
  • Previous or current gastric neoplasm.
  • Neurological or systemic diseases.
  • Pregnant, including the period of breastfeeding.
  • Patients receiving chemotherapy or radiotherapy.
  • Cognitive, psychosomatic or psychiatric illnesses that may affect the data obtained.
  • Basic systemic disease of rheumatic origin (for example, arthritis, osteoarthritis, gout and psoriasis).
  • Cerebrovascular and brain diseases.
  • Arrhythmia and other cardiac problems.
  • Implanted electronic devices.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nursing, Physiotherapy and Podiatry Faculty

Seville, Spain, 41009, Spain

RECRUITING

MeSH Terms

Conditions

Bruxism

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesHabitsBehavior

Study Officials

  • Lourdes M Fernández Seguín, PhD

    University of Seville

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lourdes M Fernández Seguín, PhD

CONTACT

Cayetano Navarro Rico, Phd Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor. Physiotherapy Department

Study Record Dates

First Submitted

February 8, 2023

First Posted

March 2, 2023

Study Start

March 1, 2023

Primary Completion

March 1, 2025

Study Completion

March 1, 2026

Last Updated

February 26, 2025

Record last verified: 2024-05

Locations